About Jonathan Wachter
Jonathan Wachter is a director at Nia Therapeutics.
Jonathan Wachter first appears on SEC filings in 2022.
Experience
This experience comes from Jonathan Wachter's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jonathan Wachter in the role, so the role may have started earlier or lasted longer.
PO
Point72 Current
Head of Operations for Macro, Treasury, and Risk Technology
2022 – Present
Nia Therapeutics, Inc. Current
Director
2021 – Present · Allston, MA
Develops a brain implant to treat memory loss in people with traumatic brain injuries.
MH
Mint House
Chief Revenue Officer and Chief Strategy Officer
2022
CI
Citadel
Non-compete period
2020 – 2021
JC
JPMorgan Chase & Co.
Managing Director, Head of Asset and Liability Management Strategy
2011 – 2020
MC
McKinsey & Company
Engagement Manager
2006 – 2011
TG
The Blackstone Group
Private Equity Analyst
2001 – 2004
Key Colleagues at Startups
The people Jonathan Wachter works with at each company, as listed on that company's latest Form D.
Nia Therapeutics, Inc. · Form D/A, Jun 3, 2026
Michael Kahana
Founder and CEO, director
Daniel Rizzuto
Founder, President and CTO, director
Daniel Utin
Chief Software Architect
LG
Larry Greenberg
Director
Milton Morris
Independent Board Director